Drawing for IGEM

USPTO serial 88337703

IGEM

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
CHISOLM, KEVON
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IGEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research; clinical trials; conducting clinical trials for pharmaceutical products; providing information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services in the fields of oncology, immunology and immuno-oncologyACTIVE
044Medical services; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of cancerous diseases; pharmaceutical services; pharmaceutical advisory services; laboratory analysis services relating to the treatment of persons; laboratory analysis services relating to the diagnosis and treatment of cancerous diseases; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncologyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2020MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Nov 5, 2020ABN1ABANDONMENT - EXPRESS MAILED
Nov 4, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED
Nov 3, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 3, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 3, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 3, 2020GNSIINQUIRY TO SUSPENSION E-MAILED
Sep 3, 2020CNSISUSPENSION INQUIRY WRITTEN
Aug 26, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 19, 2020ALIEASSIGNED TO LIE
Jan 21, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 21, 2020GNSLLETTER OF SUSPENSION E-MAILED
Jan 21, 2020CNSLSUSPENSION LETTER WRITTEN
Jan 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 16, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 16, 2019GNSIINQUIRY TO SUSPENSION E-MAILED
Dec 16, 2019CNSISUSPENSION INQUIRY WRITTEN
May 22, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 22, 2019GNSLLETTER OF SUSPENSION E-MAILED
May 22, 2019CNSLSUSPENSION LETTER WRITTEN
May 22, 2019DOCKASSIGNED TO EXAMINER
Apr 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance